...on identifying and characterizing activators of cardiac myosin as back-up and follow-on potential drug candidates to CK-1827452. Amgen has obtained an option for an exclusive license to develop and commercialize CK-1827452, subject to Cytokinetics' development...

...Development, Symphogen; Dr. Masamichi Koike, CEO and President, BioWa; and Dr. Margaret Karow, Executive Director, Research, Amgen, to discuss whether antibodies have actually come closer to being a "magic bullet" or are just another promising drug class among...

...the Bay Area where it will make official stops in Santa Rosa, Sausalito, Santa Cruz and San Jose. "San Jose is honored to host the Amgen Tour of California every year since its inception," Mayor Chuck Reed said in a prepared statement. "As a city that the...

...will be made soon, but Amgen cannot speculate on the timing of the FDA’s response,” an Amgen spokeswoman tells Reuters. “Amgen continues to work with the FDA to assist in the completion of the review process.” Just 10 days ago, BusinessWire issued a press...

...central nervous system and lung conditions. EPIX also has collaborations with leading organizations, including GlaxoSmithKline, Amgen, Cystic Fibrosis Foundation Therapeutics and Bayer Schering Pharma. For more information, please visit the company's website...

...of Health Bulgaria- Head Expert OBIG- Austrian Health Institute- Health Economist Leading Pharmaceutical Companies Amgen- Medical Director CEE AstraZeneca- Medical Director, Leader for CEE Pricing & Reimbursement Group Communication Respected Doctors University...

...Visalia and Merced on Wednesday were named host cities for the 2009 Amgen Tour of California, setting the stage for more than 130 of the world's top cyclists to race through the central San Joaquin Valley for two days in February. The nine-day, nine-stage...

...This method won't work for products already out there in circulation, because any addition to an existing product, like say, Amgen's EPO, would have to go back through the testing and approval process. Which costs money. Big Money. And of course, now that...

...to company spokesman Mary Klem. The company recently awarded a research grant to improve on current EPO testing methods. "Amgen is committed to combating inappropriate use of its vital medicines," Klem said. The International Olympic Committee plans to conduct...

...This ETF tracks an index of 152 of the leading biotech companies that trade on that exchange. The group includes companies like Amgen (AMGN), Celgene (CELG) and Gilead Sciences (GILD). The fund is up a decent 5.1% year to date. But Lydon isn't looking to flip...